| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |